跳至主要内容
临床试验/NL-OMON50004
NL-OMON50004已完成2 期

Acetazolamide in Aneurysmal Subarachnoid Hemorrhage - ASH

Radiologie0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

Trial ended prematurely

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • >=18 years old
  • Aneurysm confirmed by the presence of subarachnoid blood by computed tomography (CT) or lumbar puncture and by visualization of the aneurysm on either CT angiography, MR angiography or digital subtraction angiography
  • Hospital arrival <=120 hours of ictus
  • Adequate treatment of the aneurysm

排除标准

  • Intensive care (IC) required for >120 hours after ictus (i.e., during inclusion window)
  • Perimesencephalic bleeding
  • Traumatic SAH
  • Severe liver dysfunction or severe renal dysfunction
  • Allergic reaction for sulfomides
  • Any contraindication for MR imaging (e.g. metal objects within or around the body)
  • Pregnancy or women who are breastfeeding
  • Addison*s disease
  • Phenytoin use

研究者

发起方
Radiologie

相似试验

Acetazolamide in Aneurysmal Subarachnoid Hemorrhage | 临床试验